These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

118 related items for PubMed ID: 7408390

  • 1. Atenolol kinetics in renal failure.
    McAinsh J, Holmes BF, Smith S, Hood D, Warren D.
    Clin Pharmacol Ther; 1980 Sep; 28(3):302-9. PubMed ID: 7408390
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Pharmacokinetics of atenolol in patients with terminal renal failure and influence of haemodialysis.
    Flouvat B, Decourt S, Aubert P, Potaux L, Domart M, Goupil A, Baglin A.
    Br J Clin Pharmacol; 1980 Apr; 9(4):379-85. PubMed ID: 7378254
    [Abstract] [Full Text] [Related]

  • 4. Kinetics and absolute bioavailability of atenolol.
    Mason WD, Winer N, Kochak G, Cohen I, Bell R.
    Clin Pharmacol Ther; 1979 Apr; 25(4):408-15. PubMed ID: 428185
    [Abstract] [Full Text] [Related]

  • 5. Clinical pharmacologic observations on atenolol, a beta-adrenoceptor blocker.
    Brown HC, Carruthers SG, Johnston GD, Kelly JG, McAinsh J, McDevitt DG, Shanks RG.
    Clin Pharmacol Ther; 1976 Nov; 20(5):524-34. PubMed ID: 10125
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Single intravenous dose kinetics accumulation of atenolol in patients with impaired renal function and on hemodialysis.
    Kirch W, Schäfer M, Braun M.
    Arch Toxicol Suppl; 1980 Nov; 4():366-9. PubMed ID: 6933939
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Clinical experience with atenolol in patients with chronic liver disease.
    Kirch W, Schäfer-Korting M, Mutschler E, Ohnhaus EE, Braun W.
    J Clin Pharmacol; 1983 Apr; 23(4):171-7. PubMed ID: 6863581
    [Abstract] [Full Text] [Related]

  • 11. Pharmacokinetics of atenolol and its clinical consequences in patients with angina pectoris.
    van der Vijgh WJ, Majid PA, de Feyter PJ, Wardeh R, van der Wall EE.
    Int J Clin Pharmacol Ther Toxicol; 1980 Sep; 18(9):375-7. PubMed ID: 7005122
    [Abstract] [Full Text] [Related]

  • 12. Clinical pharmacokinetics of atenolol--a review.
    Kirch W, Görg KG.
    Eur J Drug Metab Pharmacokinet; 1982 Sep; 7(2):81-91. PubMed ID: 6749509
    [Abstract] [Full Text] [Related]

  • 13. Butofilolol pharmacokinetics in chronic renal insufficiency.
    Jeanniot JP, Houin G, Ledudal P, Cautreels W, Giudicelli CP, Tillement JP.
    Int J Clin Pharmacol Res; 1984 Sep; 4(3):165-73. PubMed ID: 6149194
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. A dose ranging study of atenolol in hypertension: fall in blood pressure and plasma renin activity, beta-blockade and steady-state pharmacokinetics.
    Ishizaki T, Oyama Y, Suganuma T, Sasaki T, Nakaya H, Shibuya T, Sato T.
    Br J Clin Pharmacol; 1983 Jul; 16(1):17-25. PubMed ID: 6349668
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Pharmacokinetics of atenolol in patients with renal impairment.
    Sassard J, Pozet N, McAinsh J, Legheand J, Zech P.
    Eur J Clin Pharmacol; 1977 Nov 14; 12(3):175-80. PubMed ID: 590303
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Relationship between blood level of atenolol and pharmacologic effect.
    Amery A, De Plaen JF, Lijnen P, McAinsh J, Reybrouck T.
    Clin Pharmacol Ther; 1977 Jun 14; 21(6):691-9. PubMed ID: 324694
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.